Table 2.

Clinical characteristics of children with chronic immune thrombocytopenia (CITP) and age-matched healthy controls (B1 and B2).

	CITP (n = 34)	B1 (n = 64)	B2 (n = 47)
Mean age (±SD)	12.1 (±4.1) years	10.9 (±3.5) years	10.6 (±3.2) years
Males (%)	17 (50)	35 (55.7)	29 (61.7)
Mean duration of CITP (±SD) at time of sampling	4.4 (±3.1) years
Ongoing therapy n (%)	Eltrombopag: 11 (31.4) MMF: 2 (5.7) Eltrombopag + MMF: 2 (5.7) Sirolimus: 1 (2.9)

n: number; SD: standard deviation; %: percentage; MMF: mofetil mycophenolate.